EUVIMEDAvasta EUVIMED
Crossref

Risk Factors for Postoperative Hyperbilirubinemia in Living Donors Undergoing Living Donor Liver Transplantation

Youngjin Kim iD, Kwang-Woong Lee iD, YoungRok Choi iD, Su Young Hong iD, Suk Kyun Hong iD

Clinical Transplantation · 2026-05 · 40 (5)

DOI: 10.1111/ctr.70567 ↗

At a glance

Journal article in Clinical Transplantation, published online on 2026-05-15. Written by Youngjin Kim and 4 co-authors. Institution: Department of Surgery, National Cancer Center of Korea Koyang, Kyungki-do, Republic of Korea. Major MEDLINE topics: Liver Transplantation, Living Donors, Hyperbilirubinemia, Postoperative Complications. 21 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

Post‐hepatectomy liver failure (PHLF) is a major concern in living donor liver transplantation (LDLT). Although predictors of PHLF have been described, large‐scale analyses are limited. Prior evidence linking postoperative peak total bilirubin (TB) with PHLF supports its use as an indirect marker of hepatic dysfunction.

Methods

This retrospective study included 1003 living liver donors undergoing LDLT. As no donor developed PHLF, postoperative hyperbilirubinemia—defined as peak TB > 7 mg/dL—was used as a surrogate endpoint. Donors were grouped accordingly. Demographic, surgical, volumetric, and laboratory variables were analyzed using univariate and multivariate methods. Thresholds for continuous predictors were examined to identify meaningful cutoffs.

Results

Postoperative hyperbilirubinemia occurred in 61 donors (6.1%). Higher preoperative TB, male sex, and smaller remnant liver volume independently predicted peak TB > 7 mg/dL. Preoperative TB had the strongest association (OR 14.54), followed by male sex (OR 8.89) and remnant liver volume (OR 1.14). Threshold analysis identified cutoff values of preoperative TB ≥ 1.6 mg/dL and remnant liver volume < 32.7% as potential risk indicators.

Conclusions

Higher preoperative TB, male sex, and smaller remnant liver volume predict postoperative hyperbilirubinemia in living donors. Although PHLF did not occur, peak TB may reflect hepatic dysfunction and aid donor risk stratification.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationLiving DonorsHyperbilirubinemiaPostoperative ComplicationsHepatectomyHumansMaleFemaleRisk FactorsRetrospective StudiesPrognosisAdultFollow-Up StudiesMiddle Aged

Author keywords

liver regenerationliving donor liver transplantationpostoperative hyperbilirubinemiapreoperative total bilirubinremnant liver volumerisk factors

Authors and institutions

  • Department of Surgery, National Cancer Center of Korea Koyang, Kyungki-do, Republic of Korea.
  • Department of Surgery, Seoul National University Hospital, Seoul, Seoul, Republic of Korea.

ORCID profiles: Youngjin Kim, Kwang-Woong Lee, YoungRok Choi, Su Young Hong, Suk Kyun Hong

Cite

APA

Kim, Y., Lee, K. W., Choi, Y., Hong, S. Y., & Hong, S. K. (2026). Risk Factors for Postoperative Hyperbilirubinemia in Living Donors Undergoing Living Donor Liver Transplantation. Clinical Transplantation, 40(5). https://doi.org/10.1111/ctr.70567

Vancouver

Kim Y, Lee KW, Choi Y, Hong SY, Hong SK. Risk Factors for Postoperative Hyperbilirubinemia in Living Donors Undergoing Living Donor Liver Transplantation. Clinical Transplantation. 2026;40(5). doi:10.1111/ctr.70567

BibTeX
@article{Kim2026,
  author = {Kim, Youngjin and Lee, Kwang-Woong and Choi, YoungRok and Hong, Su Young and Hong, Suk Kyun},
  title = {Risk Factors for Postoperative Hyperbilirubinemia in Living Donors Undergoing Living Donor Liver Transplantation},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {5},
  doi = {10.1111/ctr.70567}
}
Start for free →